Inhibition/NN
of/IN
nuclear/JJ
factor/NN
kappa/NN
B/NN
subunit/NN
p65/NN
mRNA/NN
accumulation/NN
in/IN
lipopolysaccharide-stimulated/JJ
human/JJ
monocytic/JJ
cells/NNS
treated/VBN
with/IN
sodium/NN
salicylate/NN
./.

Lipopolysaccharide/NN
is/VBZ
one/CD
of/IN
the/DT
most/RBS
potent/JJ
trigger/NN
substances/NNS
for/IN
monocytes/NNS
and/CC
macrophages/NNS
causing/VBG
secretion/NN
of/IN
inflammatory/JJ
mediators/NNS
such/JJ
as/IN
tumor/NN
necrosis/NN
factor/NN
and/CC
interleukin-1/NN
./.
=====
The/DT
nature/NN
of/IN
the/DT
nuclear/JJ
factors/NNS
involved/VBN
in/IN
regulation/NN
of/IN
these/DT
cytokine/NN
genes/NNS
is/VBZ
still/RB
unknown/JJ
./.
=====
Nuclear/JJ
factor/NN
kappa/NN
B/NN
(/(
NF-kappa/NN
B/NN
;/:
heterodimer/NN
of/IN
p50/NN
and/CC
p65/NN
)/)
proteins/NNS
have/VBP
been/VBN
suggested/VBN
to/TO
play/VB
an/DT
important/JJ
role/NN
in/IN
gene/NN
transcription/NN
of/IN
inflammatory/JJ
mediators/NNS
when/WRB
monocytes/NNS
are/VBP
stimulated/VBN
with/IN
lipopolysaccharide/NN
./.
=====
Nonsteroidal/JJ
anti-inflammatory/JJ
drugs/NNS
such/JJ
as/IN
salicylates/NNS
have/VBP
been/VBN
used/VBN
to/TO
treat/VB
symptoms/NNS
of/IN
inflammation/NN
,/,
and/CC
a/DT
new/JJ
mechanism/NN
of/IN
drug/NN
action/NN
was/VBD
suggested/VBN
recently/RB
./.
=====
Salicylates/NNS
have/VBP
been/VBN
shown/VBN
to/TO
inhibit/VB
lipopolysaccharide-induced/JJ
gene/NN
transcription/NN
via/IN
inhibition/NN
of/IN
NF-kappa/NN
B/NN
activation/NN
by/IN
preventing/VBG
the/DT
degradation/NN
of/IN
NF-kappa/NN
B/NN
inhibitor/NN
"/``
I/NN
kappa/NN
B/NN
"/''
,/,
blocking/VBG
the/DT
translocation/NN
of/IN
NF-kappa/NN
B/NN
into/IN
the/DT
nuclear/JJ
compartment/NN
./.
=====
However/RB
,/,
the/DT
nature/NN
of/IN
the/DT
subunit/NN
involved/VBN
in/IN
this/DT
mechanism/NN
has/VBZ
not/RB
been/VBN
defined/VBN
./.
=====
To/TO
examine/VB
the/DT
mechanisms/NNS
by/IN
which/WDT
salicylates/NNS
affect/VBP
cytokine/NN
gene/NN
transcription/NN
,/,
the/DT
amount/NN
of/IN
active/JJ
and/CC
inactive/JJ
NF-kappa/NN
B/NN
and/CC
NF-kappa/NN
B/NN
mRNA/NN
,/,
in/IN
Porphyromonas/NN
gingivalis/NN
lipopolysaccharide-stimulated/JJ
human/JJ
monocytic/JJ
cells/NNS
was/VBD
assessed/VBN
./.
=====
High/JJ
doses/NNS
of/IN
sodium/NN
salicylate/NN
suppressed/VBD
NF-kappa/NN
B/NN
p65/NN
mRNA/NN
accumulation/NN
,/,
resulting/VBG
in/IN
suppression/NN
of/IN
total/JJ
NF-kappa/NN
B/NN
,/,
p50/NN
on/IN
tissue/NN
oligonucleotide/NN
had/VBD
no/DT
effects/NNS
on/IN
lipopolysaccharide-induced/JJ
NF-kappa/NN
B/NN
activation/NN
./.
=====
The/DT
data/NNS
demonstrate/VBP
that/IN
the/DT
p65/NN
subunit/NN
of/IN
NF-kappa/NN
B/NN
is/VBZ
inhibited/VBN
by/IN
salicylate/NN
treatment/NN
and/CC
highlight/VBP
the/DT
role/NN
of/IN
salicylate/NN
in/IN
the/DT
control/NN
of/IN
gene/NN
expression/NN
of/IN
inflammatory/JJ
mediators/NNS
./.